Our study revealed that the LINC00571/HNRNPK/ILF2/IDH2 axis promoted the progression of triple-negative breast cancer by regulating tricarboxylic acid cycle metabolites. The gene discussed is HNRNPK; the disease is triple-negative breast carcinoma.